Robert H. Miller, PhD, vice dean of the George Washington University (GW) School of Medicine and Health Sciences (SMHS), announced that he will step down from his leadership role, effective Oct. 31, 2026.
While stepping away from his executive position, Miller will remain a faculty member in the Department of Anatomy and Cell Biology, continuing his work in the neuroscience laboratory through April 2027, when he will retire from GW.
“Dr. Miller has been a wonderful thought partner and advisor since I arrived here,” said Andrew W. Artenstein, MD, MBA, interim vice president for health affairs at GW and dean of SMHS. “His deep institutional knowledge, unwavering commitment to academic excellence, and sage guidance have been invaluable to me and to our entire leadership team. I have truly appreciated his willingness to provide not only informed dissent but to offer thoughtful, potential solutions to the challenges at hand. His passion for discovery and his dedication to SMHS and the university leave a lasting legacy.”
Since joining GW in 2014, Miller has made numerous important contributions to the school, the university, and the broader scientific community. Installed as the Vivian Gill Distinguished Research Professor in 2015, he is an internationally recognized neuroscientist whose research has been funded continuously for more than 40 years. His research has provided targeted insights into a variety of neuropathological conditions that have informed a number of clinical trials in the United States and Europe.
He led efforts to identify research funding, assess and identify areas for research expansion, cultivate research relationships with outside entities, and guide research-related faculty development to support SMHS research priorities. As a result, the school has seen a threefold increase in research expenditures, faculty and student recruitment at the highest levels, and the development of state-of-the-art research facilities.
“Over the last decade or so we have dramatically enhanced the research across the university, and more specifically the current strength of the research in SMHS is something everyone should be proud of,” Miller said of his legacy, adding that the “faculty, staff, and trainees have been outstanding.”
During his tenure, Miller also oversaw multiple research infrastructure projects including the creation of the GMP Cellular Processing and Manufacturing Facility and renovation of the 13,500-square-foot lab space in Ross Hall.
“If we are going to recruit the best and the brightest, we need to provide an environment that will facilitate their research. That requires research space,” Miller said. “There is no better motivation for research discovery than a significant investment into facilities, making them an easier space in which to conduct high impact science.”
Beyond his SMHS leadership, Miller’s university-wide efforts have been significant. He answered the call to serve twice as GW’s vice president for research, expertly guiding the central research enterprise through pivotal moments, including the COVID-19 pandemic and shifting federal regulatory landscapes. Most recently, his steady stewardship helped advance GW’s ongoing clinical transitions.
Over the course of his career, Miller has authored more than 200 widely cited publications that reflect the profound, lasting impact of his scholarship. His research interests focus on how brain and spinal cord cells develop and behave, how diseases and injuries disrupt them, and whether stem cells or other treatments could help repair the nervous system or prevent abnormal cell growth. In recognition of those research contributions, Miller has received many prestigious honors, including the Jacob Javits Neuroscience Award and an Alfred P. Sloan Fellowship, and he remains a Fellow of the National Academy of Inventors.
